Who invested in Sur180 Therapeutics?
Sur180 Therapeutics's investors include National Institutes of Health.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$2.4Mraised across 1 round since 2025, from 1 source
From Sur180 Therapeutics's own website: 2 on the team.
Sur180 Therapeutics's investors include National Institutes of Health.
Sur180 Therapeutics has raised $2.4M across 1 round since 2025.
Sur180 Therapeutics's most recent round was a Grant of $2.4M in Jul 2025.
Its most recent round, $2.4M in Jul 2025, is also its largest on record.
Sur180 Therapeutics's first round on record, in Jul 2025, was backed by National Institutes of Health.
Sur180 Therapeutics's latest named round is a Grant, in Jul 2025.
Sur180 Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.